Penn's Kiran Musunuru spoke with The Inquirer about the future of CRISPR technology.

Lawmakers are trying to restore access to GLP-1 weight loss drugs, like Ozempic and Wegovy, after Ohio removed medical ...

Some health experts view GLP-1s as a promising option for PCOS, which lacks a standard treatment and affects millions of ...

Sharon Osbourne lost weight with the help of Ozempic after calling herself a 'food addict' and ultimately warning against the ...

That's what happened beginning in November of last year, anyway. The company announced solid testing results for VK2735. But ...

AI scanned animal venom peptides and found 386 potential antibiotics. Most killed drug-resistant bacteria in tests and were ...

On April 29, 2025, Hims & Hers and Novo Nordisk unveiled a landmark collaboration to bring Wegovy—Novo's blockbuster ...

Sino Biopharma will acquire LaNova Medicines, which has licensed cancer drugs for Merck and AstraZeneca, for $951 million.

An article in The Journal For Nurse Practitioners found that Depo-Testosterone was the most cost-efficient TRT option, and ...

The wellness trend is driving demand for functional, protein-rich foods like yogurt. Here’s what’s fueling growth in the ...

Officials with the Food and Drug Administration have approved the continued sales of tobacco-flavored e-cigarettes and refill ...

Discover 8 trends in surgery under investigation for safety risks, including robotic surgery, stem cells, and surgical mesh.